Unnamed: 0,title,date,stock,sentiment
726938.0,"Kindred Biosciences Expects Restructuring To Be Completed In Q3 2020; To Record Charge Of About $2.3M For Severance Payments, Health Care Benefits, Exclusive Of Stock Compensation",2020-06-08 16:51:00-04:00,KIN,positive
726939.0,"Kindred Biosciences To Reduce Operating Expenses And Prioritize Investment In Highest Value, Late Stage Programs",2020-06-08 16:03:00-04:00,KIN,positive
726940.0,52 Stocks Moving In Wednesday's Mid-Day Session,2020-05-20 13:17:00-04:00,KIN,neutral
726941.0,Kindred Biosciences shares are trading higher the company announced a coronavirus vaccine manufacturing agreement with Vaxart.,2020-05-20 08:37:00-04:00,KIN,positive
726942.0,Vaxart Says Has Selected Its Lead COVID-19 Coronavirus Candidat,2020-05-20 08:21:00-04:00,KIN,neutral
726943.0,Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement With Vaxart,2020-05-20 07:58:00-04:00,KIN,positive
726944.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,KIN,negative
726945.0,"Kindred Biosciences Q1 EPS $(0.580) Misses $(0.430) Estimate, Sales $603.000K Miss $1.590M Estimate",2020-05-07 16:21:00-04:00,KIN,negative
726946.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,KIN,negative
726947.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,KIN,neutral
726948.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,KIN,negative
726949.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,KIN,neutral
726950.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,KIN,positive
726951.0,130 Biggest Movers From Yesterday,2020-03-18 06:06:00-04:00,KIN,neutral
726952.0,94 Stocks Moving In Tuesday's Mid-Day Session,2020-03-17 12:41:00-04:00,KIN,neutral
726953.0,"Stifel Maintains Buy on Kindred Biosciences, Lowers Price Target to $13",2020-03-17 10:09:00-04:00,KIN,negative
726954.0,10 Biggest Price Target Changes For Tuesday,2020-03-17 09:06:00-04:00,KIN,neutral
726955.0,"H.C. Wainwright Maintains Buy on Kindred Biosciences, Lowers Price Target to $9",2020-03-17 07:29:00-04:00,KIN,negative
726956.0,"Kindred Biosciences Q4 EPS $(0.4) Misses $(0.36) Estimate, Sales $1.401M Beat $1.3M Estimate",2020-03-16 16:03:00-04:00,KIN,negative
726957.0,Kindred Biosciences's Earnings Outlook,2020-03-16 08:18:00-04:00,KIN,neutral
726958.0,"Earnings Scheduled For March 16, 2020",2020-03-16 04:03:00-04:00,KIN,neutral
726959.0,"The Week Ahead In Biotech: COVID-19 Updates, Tapering Earnings Flow, Eton's Seizure Drug Review",2020-03-15 09:55:00-04:00,KIN,neutral
726960.0,140 Biggest Movers From Friday,2020-03-02 04:43:00-05:00,KIN,neutral
726961.0,Kindred Biosciences Announces Half-Life Extension Technology For Canine Antibodies,2020-01-08 16:03:00-05:00,KIN,neutral
726962.0,Kindred Biosciences Unveils Positive Results from Pilot Study of its Interleukin-4R Monoclonal Antibody Being Developed for the Treatment of Atopic Dermatitis in Dogs,2019-12-16 08:06:00-05:00,KIN,positive
726963.0,Kindred Biosciences Reports EC Approval Of Mirataz 20 mg/g Transdermal Ointment for Cats,2019-12-12 09:07:00-05:00,KIN,positive
726964.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,KIN,positive
726965.0,Kindred Biosciences Receives FDA Approval Of Zimeta For The Control Of Pyrexia In Horses,2019-11-25 16:04:00-05:00,KIN,positive
726966.0,"Kindred Biosciences Q3 EPS $(0.39) Misses $(0.37) Estimate, Sales $1.1M Miss $1.66M Estimate",2019-11-12 16:34:00-05:00,KIN,negative
726967.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,KIN,neutral
726968.0,Kindred Biosciences Announces Positive Opinion from CVMP in the European Union for Mirataz For Cats Experiencing Poor Appetite and Weight Loss,2019-10-10 16:03:00-04:00,KIN,negative
726969.0,56 Biggest Movers From Friday,2019-09-16 05:29:00-04:00,KIN,neutral
726970.0,Kindred Biosciences Awarded Contract By National Cancer Institute In Support Of PREVENT Cancer Program,2019-09-10 07:05:00-04:00,KIN,negative
726971.0,82 Biggest Movers From Friday,2019-08-05 05:40:00-04:00,KIN,neutral
726972.0,40 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-02 04:10:00-04:00,KIN,neutral
726973.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,KIN,negative
726974.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,KIN,neutral
726975.0,35 Stocks Moving In Monday's Pre-Market Session,2019-07-29 08:30:00-04:00,KIN,neutral
726976.0,Kindred Biosciences Announces Results From Pilot Field Effectiveness Study Of Its Interleukin-31 Monoclonal Antibody For The Treatment Of Atopic Dermatitis In Dogs,2019-07-29 07:14:00-04:00,KIN,neutral
726977.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,KIN,negative
726978.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,KIN,neutral
726979.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,KIN,neutral
726980.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,KIN,negative
726981.0,58 Biggest Movers From Yesterday,2019-07-17 04:59:00-04:00,KIN,neutral
726982.0,41 Stocks Moving In Tuesday's Mid-Day Session,2019-07-16 12:10:00-04:00,KIN,neutral
726983.0,10 Biggest Price Target Changes For Tuesday,2019-07-16 09:33:00-04:00,KIN,neutral
726984.0,"B. Riley Downgrades Kindred Biosciences to Neutral, Lowers Price Target to $8.5",2019-07-16 07:49:00-04:00,KIN,negative
726985.0,"Barclays Initiates Coverage On Kindred Biosciences with Overweight Rating, Announces $13 Price Target",2019-06-11 07:06:00-04:00,KIN,negative
726986.0,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer",2019-06-04 07:45:00-04:00,KIN,negative
726987.0,"Companies Which Will Be Presenting At LD Micro's 9th Annual Micro Invitational Tues., Jun. 4, 2019",2019-06-03 16:57:00-04:00,KIN,neutral
726988.0,"Stifel Nicolaus Initiates Coverage On Kindred Biosciences, Inc. - Common Stock with Buy Rating, Announces $14 Price Target",2019-05-23 08:46:00-04:00,KIN,neutral
726989.0,Kindred Biosciences Q1 EPS $(0.42) Misses $(0.41) Estimate,2019-05-09 16:52:00-04:00,KIN,negative
726990.0,"The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut",2019-05-09 07:56:00-04:00,KIN,neutral
726991.0,64 Biggest Movers From Yesterday,2019-03-08 05:22:00-05:00,KIN,neutral
726992.0,51 Stocks Moving In Thursday's Mid-Day Session,2019-03-07 12:32:00-05:00,KIN,neutral
726993.0,Kindred Biosciences shares are trading lower after the company announced worse-than-expected Q4 EPS results.,2019-03-06 16:35:00-05:00,KIN,neutral
726994.0,Kindred Biosciences Q4 EPS $(0.46) Misses $(0.43) Estimate,2019-03-06 16:04:00-05:00,KIN,negative
726995.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",2019-03-06 07:39:00-05:00,KIN,negative
726996.0,"The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial",2019-01-24 07:45:00-05:00,KIN,negative
726997.0,52 Biggest Movers From Friday,2019-01-22 05:08:00-05:00,KIN,neutral
726998.0,36 Stocks Moving In Friday's Mid-Day Session,2019-01-18 12:30:00-05:00,KIN,neutral
726999.0,Kindred Biosciences shares are trading lower after the company announced a 4.215 million common stock offering at $9.50 per share.,2019-01-18 09:51:00-05:00,KIN,positive
727000.0,Kindred Biosciences Prices 4.215M Share Common Stock Offering At $9.50/Share,2019-01-18 09:36:00-05:00,KIN,positive
727001.0,"The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug",2019-01-18 07:49:00-05:00,KIN,neutral
727002.0,Kindred Biosciences Says it Expects 2018 Net Product Revenue of ~$2M,2019-01-17 16:26:00-05:00,KIN,neutral
727003.0,Kindred Biosciences Reports Proposed Common Stock Offering; No Size Disclosed,2019-01-17 16:08:00-05:00,KIN,negative
727004.0,Kindred Biosciences Reports Results From Pilot Field Effectiveness Study Of epoCat for the Management of Non-Regenerative Anemia in Cats and Availability of MiratazÂ® at Banfield Pet Hospital,2019-01-14 07:32:00-05:00,KIN,neutral
727005.0,"Kindred Biosciences Q3 EPS $(0.39) Misses $(0.37) Estimate, Sales $640K",2018-11-07 16:17:00-05:00,KIN,negative
727006.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,KIN,negative
727007.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,KIN,neutral
727008.0,82 Biggest Movers From Yesterday,2018-11-01 04:38:00-04:00,KIN,neutral
727009.0,66 Stocks Moving In Wednesday's Mid-Day Session,2018-10-31 12:50:00-04:00,KIN,neutral
727010.0,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",2018-10-31 08:20:00-04:00,KIN,negative
727011.0,Kindred Biosciences shares are up 15.8% after the company reported 'positive' results from a study of IL-31 for atopic dermatitis in dogs and announced the issuance od a US patent.,2018-10-30 17:17:00-04:00,KIN,positive
727012.0,Kindred Biosciences Announces 'Positive' Results from Pilot Effectiveness Study of its Fully Caninized IL-31 Antibody for the Treatment of Atopic Dermatitis in Dogs and Issuance of US Patent,2018-10-30 16:33:00-04:00,KIN,neutral
727013.0,"Kindred Biosciences Q2 EPS $(0.39), Inline",2018-08-09 16:18:00-04:00,KIN,neutral
727014.0,"The Daily Biotech Pulse: Ampio Slides On Offering, Sangamo's Positive Trial Results, Insys Earnings",2018-08-09 08:39:00-04:00,KIN,positive
727015.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,KIN,neutral
727016.0,"Benzinga's Top Upgrades, Downgrades For August 7, 2018",2018-08-07 09:03:00-04:00,KIN,positive
727017.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,KIN,negative
727018.0,Ladenburg Thalmann Downgrades Kindred Biosciences to Neutral,2018-08-07 07:23:00-04:00,KIN,neutral
727019.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,KIN,neutral
727020.0,"Cantor Fitzgerald Initiates Coverage On Kindred Biosciences with Overweight Rating, Announces $20 Price Target",2018-07-24 08:47:00-04:00,KIN,negative
727021.0,"Lake Street Initiates Coverage On Kindred Biosciences with Buy Rating, Announces $30 Price Target",2018-07-23 08:45:00-04:00,KIN,neutral
727022.0,Stocks Which Set New 52-Week High Yesterday,2018-07-20 09:05:00-04:00,KIN,neutral
727023.0,"Benzinga's Daily Biotech Pulse: PTC To Buy Agilis, Zynerba To Offer Shares, Intuitive Surgical's Strong Q2",2018-07-20 07:53:00-04:00,KIN,positive
727024.0,"Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares",2018-07-18 08:42:00-04:00,KIN,positive
727025.0,30 Biggest Movers From Yesterday,2018-07-10 05:02:00-04:00,KIN,neutral
727026.0,28 Stocks Moving In Monday's Mid-Day Session,2018-07-09 12:16:00-04:00,KIN,neutral
727027.0,Kindred Biosciences Announces Commercial Availability of Mirataz to Veterinarians in the United States,2018-07-09 08:32:00-04:00,KIN,positive
727028.0,Kindred Biosciences Announces the Termination of Its At-The-Market Equity Offering Program,2018-06-20 16:01:00-04:00,KIN,neutral
727029.0,Kindred Biosciences Prices 4.6M Share Common Stock Offering At $9.50/Share,2018-06-20 09:11:00-04:00,KIN,positive
727030.0,"Kindred Biosciences Announces Common Stock Offering, No Size Disclosed",2018-06-19 16:01:00-04:00,KIN,negative
727031.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,KIN,neutral
727032.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",2018-06-14 08:11:00-04:00,KIN,negative
727033.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,KIN,negative
727034.0,Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO,2018-06-01 08:16:00-04:00,KIN,neutral
727035.0,"Kindred Biosciences Q1 EPS $(0.36), Inline",2018-05-08 17:24:00-04:00,KIN,neutral
727036.0,"Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure",2018-05-08 07:55:00-04:00,KIN,neutral
727037.0,Kindred Biosciences Announces Up to a $50M Offering,2018-05-07 07:10:00-04:00,KIN,neutral
727038.0,Kindred Biosciences Receives FDA Approval of Mirataz,2018-05-07 07:02:00-04:00,KIN,positive
727039.0,"Kindred Biosciences Halted, News Pending",2018-05-07 06:59:00-04:00,KIN,neutral
727040.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,KIN,neutral
727041.0,"UPDATE: Kindred Says FDA Has No Added Questions, Requests For Co. Related To Submission",2018-04-24 16:44:00-04:00,KIN,negative
727042.0,"Kindred Biosciences Reports Received Response From FDA For Chemistry, Manufacturing, Controls Technical Section For Zimeta IV For Control Of Fever In Horses",2018-04-24 16:44:00-04:00,KIN,neutral
727043.0,Kindred Biosciences Reports Q4 EPS $(0.35) vs $(0.31) Est.,2018-03-01 16:41:00-05:00,KIN,neutral
727044.0,Kindred Biosciences S-3 Shows Registration For $150M Mixed Securities Shelf Offering,2018-01-18 12:02:00-05:00,KIN,positive
727045.0,"Benzinga's Top Upgrades, Downgrades For December 27, 2017",2017-12-27 09:15:00-05:00,KIN,positive
727046.0,KindredBio Announces Submission of European Medicines Agency Filing for Mirataz,2017-12-21 08:02:00-05:00,KIN,neutral
727047.0,KindredBio Met Primary Endpoint For Zimeta Oral For Fever In Horses,2017-12-04 08:03:00-05:00,KIN,neutral
727048.0,"H.C. Wainwright Initiates Coverage On Kindred Biosciences with Buy Rating, Announces $9.50 Price Target",2017-11-17 07:03:00-05:00,KIN,neutral
727049.0,Kindred Biosciences Reports Q3 EPS $(0.29) vs $(0.33) Est.,2017-11-07 16:50:00-05:00,KIN,neutral
727050.0,Kindred Biosciences Reports Q2 EPS $(0.29) vs $(0.32) Est.,2017-08-07 17:27:00-04:00,KIN,neutral
727051.0,Filing From Kindred Biosciences Shows 3M Share Common Stock Offering Priced At $7.85/Share,2017-07-12 17:18:00-04:00,KIN,positive
727052.0,10 Biggest Mid-Day Losers For Wednesday,2017-07-12 12:50:00-04:00,KIN,negative
727053.0,KindredBio  Prices 3M Share Offering At $7.50/Share,2017-07-12 08:45:00-04:00,KIN,positive
727054.0,"Kindred Bioscience Shares Down 3.8% In Pre-Market Following Common Stock Offering Reported Tuesday After-Hours, No Amount Disclosed",2017-07-12 08:25:00-04:00,KIN,neutral
727055.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-07-12 08:06:00-04:00,KIN,neutral
727056.0,"Kindred Biosciences Reports Offering Of Common Stock, No Amount Disclosed",2017-07-11 16:11:00-04:00,KIN,negative
727057.0,Kindred Biosciences Announces Acquisition of Kansas Manufacturing Plant For $3.75M and Execution of Commercial Manufacturing Agreement for Zimeta,2017-06-26 07:31:00-04:00,KIN,positive
727058.0,"Benzinga's Top Upgrades, Downgrades For June 16, 2017",2017-06-16 09:35:00-04:00,KIN,positive
727059.0,"Aegis Capital Initiates Coverage On Kindred Biosciences with Buy Rating, Announces $10.50 Price Target",2017-06-16 07:43:00-04:00,KIN,neutral
727060.0,"Benzinga's Top Upgrades, Downgrades For May 24, 2017",2017-05-24 09:22:00-04:00,KIN,positive
727061.0,"FBR Capital Initiates Coverage On Kindred Biosciences with Outperform Rating, Announces $10.00 Price Target",2017-05-24 07:41:00-04:00,KIN,neutral
727062.0,"Kindred Biosciences 10%+ Owner Park West Asset Management Buys 155,076 Shares @ Avg Price: $6.82 -Form4",2017-05-16 04:49:00-04:00,KIN,positive
727063.0,Kindred Biosciences Reports Q1 EPS $(0.30) vs $(0.34) Est.,2017-05-03 16:03:00-04:00,KIN,neutral
727064.0,Kindred Biosciences Reports Initiation of Enrollment for Pivotal Effectiveness of Zimeta Oral for Control of Fever in Horses,2017-05-01 07:14:00-04:00,KIN,neutral
727065.0,Kindred Biosciences Reports Q4 EPS $(0.29) vs $(0.36) Est.,2017-03-01 16:12:00-05:00,KIN,neutral
727066.0,Kindred Biosciences Receives Early Approval of Effectiveness Technical Section from FDA for Mirataz New Animal Drug Application,2017-02-06 09:02:00-05:00,KIN,positive
727067.0,KeyBanc Downgrades Kindred Biosciences to Sector Weight,2016-11-18 06:51:00-05:00,KIN,neutral
727068.0,Kindred Biosciences Reports Q3 EPS $(0.29) vs. Est. $(0.33),2016-11-07 09:03:00-05:00,KIN,neutral
727069.0,Kindred Biosciences Is 'Setting The Pace In Animal Health Biologics',2016-11-01 11:25:00-04:00,KIN,neutral
727070.0,Benzinga's Top Initiations,2016-11-01 09:31:00-04:00,KIN,positive
727071.0,"Ladenburg Thalmann Initiates Coverage On Kindred Biosciences, Inc. - Common Stock at Buy, Announces $7.50",2016-11-01 06:47:00-04:00,KIN,neutral
727072.0,UPDATE: Kindred Expects The Approval of Zimeta In 1H17 If FDA Review Process Is Rapid,2016-10-04 16:02:00-04:00,KIN,positive
727073.0,Kindred Biosciences Receives Approval of Effectiveness Technical Section From FDA For Zimeta New Animal Drug application,2016-10-04 16:01:00-04:00,KIN,positive
727074.0,Kindred Biosciences Submits Final Major New Animal Drug Application Technical Section for Safety for Mirataz to FDA and Launches KindredBio Equine Website,2016-09-30 09:12:00-04:00,KIN,positive
727075.0,Kindred Biosciences Submits Drug Application Technical Section for Effectiveness for Mirataz to FDA,2016-08-22 16:03:00-04:00,KIN,neutral
727076.0,Kindred Biosciences Reports Q2 EPS $(0.25) vs $(0.32) Est.,2016-08-08 16:11:00-04:00,KIN,neutral
727077.0,Kindred Biosciences Announces Initiation of Pilot Field Study of Atopic Dermatitis and Other Updates,2016-06-14 16:02:00-04:00,KIN,neutral
727078.0,Kindred Biosciences Reports Q1 EPS $(0.31) Vs Est $(0.32),2016-05-05 08:33:00-04:00,KIN,neutral
727079.0,"Director Mario Buys 30,000 Shares of Kindred Biosciences @$3.55/Share -Form 4",2016-03-17 10:38:00-04:00,KIN,positive
727080.0,Kindred Biosciences Submits Final Major New Animal Drug Application Technical Section for Safety for Zimeta to FDA,2016-03-15 16:01:00-04:00,KIN,positive
727081.0,Kindred Biosciences Reports Q4 EPS $(0.32) vs $(0.44) Est.,2016-03-02 16:01:00-05:00,KIN,neutral
727082.0,Kindred Biosciences Submits Zimeta New Animal Drug Application Technical Section for Effectiveness to FDA,2016-02-11 16:03:00-05:00,KIN,neutral
727083.0,UPDATE: Kindred Biosciences KIND-010 Showed 3.25% Weight Gain vs. Placebo Loss Of 1.65% With Statistical Significant Results (P=0.0042),2016-01-26 09:06:00-05:00,KIN,positive
727084.0,Kindred Biosciences Offers Results of Pilot Field Study of KIND-010 for Mgmt of Weight in Cats,2016-01-26 09:05:00-05:00,KIN,neutral
727085.0,Kindred Biosciences To Reduce Workforce By 31%,2016-01-11 08:59:00-05:00,KIN,neutral
727086.0,"Kindred Biosciences Says Will Offer corporate Update on Mon., Jan. 11",2016-01-07 09:03:00-05:00,KIN,neutral
727087.0,"Kindred Biosciences Reports Submission of KIND-012 NADA Technical Section for Chemistry, Manufacturing, Controls to FDA",2015-12-17 09:03:00-05:00,KIN,neutral
727088.0,Benzinga's Top Downgrades,2015-11-17 09:26:00-05:00,KIN,positive
727089.0,"BMO Capital Downgrades Kindred Biosciences to Market Perform, Lowers PT to $5.00",2015-11-17 07:38:00-05:00,KIN,negative
727090.0,Kindred Biosciences Shares to Resume Trade at 9 a.m. EST,2015-11-16 08:36:00-05:00,KIN,positive
727091.0,"Kindred Reports Positive Results from Pivotal Study of KIND-012 for Pyrexia: Study Met Primary Endpoint, SentiKind Study Misses Primary Endpoint",2015-11-16 08:31:00-05:00,KIN,positive
727092.0,Kindred Biosciences Shares Halted News Pending,2015-11-16 08:25:00-05:00,KIN,positive
727093.0,Kindred Biosciences Reports Q3 EPS $(0.36) vs $(0.44) Est.,2015-11-09 08:34:00-05:00,KIN,neutral
727094.0,Kindred Biosciences Reports Q2 Loss of $0.35/Share vs Loss of $0.44/Share Est.,2015-08-10 09:03:00-04:00,KIN,negative
727095.0,UPDATE: Kindred Biosciences Pilot Field Study of KIND-012 for the Control of Fever in Horses Met Primary Endpoint,2015-03-16 16:04:00-04:00,KIN,neutral
727096.0,Kindred Biosciences Announces Results of Pilot Field Study of KIND-012 for Control of Fever in Horses: Shows Primary Endpoint Met,2015-03-16 16:03:00-04:00,KIN,neutral
727097.0,KIndred Biosciences Reports Q4 EPS $(0.34) vs. Est. $(0.43),2015-03-12 16:26:00-04:00,KIN,neutral
727098.0,"Earnings Scheduled For March 12, 2015",2015-03-12 04:37:00-04:00,KIN,neutral
727099.0,S-3 from Kindred Biosciences Shows Registration for $150M Mixed Securities Shelf,2015-01-16 16:22:00-05:00,KIN,positive
727100.0,"MId-Day Losers From December 4: Kindred Biosciences, Barnes & Noble, Aeropostale",2014-12-04 13:14:00-05:00,KIN,negative
727101.0,Stocks Hitting 52-Week Lows,2014-12-04 10:21:00-05:00,KIN,negative
727102.0,Morning Market Losers,2014-12-04 09:52:00-05:00,KIN,negative
727103.0,Benzinga's Top Downgrades,2014-12-04 09:16:00-05:00,KIN,positive
727104.0,Leerink Swann Downgrades Kindred Biosciences To Market Perform,2014-12-04 08:43:00-05:00,KIN,neutral
727105.0,Benzinga's Top #PreMarket Losers,2014-12-04 08:25:00-05:00,KIN,negative
727106.0,"Leerink Swann Downgrades Kindred Biosciences to Market Perform, Lowers PT to $6.00",2014-12-04 06:11:00-05:00,KIN,negative
727107.0,Shares of Kindred Biosciences to Resume Trade at 4:30 p.m. EDT,2014-12-03 16:13:00-05:00,KIN,positive
727108.0,KindredBio Announces Will Stop Atokin Study,2014-12-03 16:08:00-05:00,KIN,negative
727109.0,Shares of Kindred Bioscience Halted News Pending,2014-12-03 16:01:00-05:00,KIN,positive
727110.0,Morning Market Losers ,2014-08-21 10:02:00-04:00,KIN,negative
727111.0,Kindred Bio Goes To The Dogs; Lead Drug Candidate Washes Out,2014-08-21 09:07:00-04:00,KIN,neutral
727112.0,Benzinga's Top #PreMarket Losers,2014-08-21 08:14:00-04:00,KIN,negative
727113.0,Kindred Biosciences Shares to Resume Trade at 4:30p.m. EDT,2014-08-20 16:25:00-04:00,KIN,positive
727114.0,"UPDATE: Kindred Biosciences Reports Results from PIVOTAL Study of CereKin in Dogs, Primary Endpoint Was Not Met",2014-08-20 16:02:00-04:00,KIN,neutral
727115.0,"Kindred Biosciences Reports Results from PIVOTAL Study of CereKin in Dogs, Primary Endpoint Was Not Met",2014-08-20 16:01:00-04:00,KIN,neutral
727116.0,Kindred Biosciences Halted News Pending,2014-08-20 16:00:00-04:00,KIN,neutral
727117.0,Kindred Biosciences Reports Q2 EPS of $(0.42) vs $(0.35) Est,2014-08-13 16:25:00-04:00,KIN,neutral
727118.0,"Morning Market Movers Friday, May 23, 2014",2014-05-23 10:44:00-04:00,KIN,neutral
727119.0,Kindred Biosciences Reports Q1 EPS of $(0.38) vs $(0.19) Est,2014-05-12 16:19:00-04:00,KIN,neutral
727120.0,"Leerink Swann Initiates Coverage on Kindred Biosciences at Outperform, Announces $32.00 PT",2014-04-14 09:08:00-04:00,KIN,neutral
727121.0,"Kindred Bio Closes Public Offering, Estimates Net Proceeds of $58.1M",2014-04-08 16:03:00-04:00,KIN,neutral
727122.0,Morning Market Losers ,2014-04-03 09:49:00-04:00,KIN,negative
727123.0,Kindred Bio Prices 3M Shares at $18/Share,2014-04-03 09:03:00-04:00,KIN,positive
727124.0,UPDATE: Kindred Bio Announces Launch of $50M Public Offering,2014-03-31 16:11:00-04:00,KIN,neutral
727125.0,Kindred Bio Announces $50M Offering of Common Stock ,2014-03-31 16:10:00-04:00,KIN,neutral
727126.0,Kindred Bio Announces Initiation of Pivotal Clinical Study for SentiKin in Dogs ,2014-03-28 09:05:00-04:00,KIN,neutral
727127.0,Morning Market Losers ,2014-03-24 09:44:00-04:00,KIN,negative
727128.0,"Roth Capital Downgrades Kindred Biosciences to Neutral, Raises PT to $25.00",2014-03-07 07:15:00-05:00,KIN,neutral
727129.0,"BMO Capital Upgrades Kindred Biosciences to Outperform, Raises Pt to $30.00",2014-02-25 07:54:00-05:00,KIN,neutral
727130.0,"13F Filing from Seth Klarman's Baupost Group Shows New Stake in Kindred Biosciences, Liquidated Stake in Oracle",2014-02-13 16:18:00-05:00,KIN,neutral
727131.0,"Roth Capital Initiates Coverage on Kindred Biosciences at Buy, Announces $20.00 PT",2014-02-04 07:24:00-05:00,KIN,neutral
727132.0,BMO Capital Downgrades Kindred Biosciences to Market Perform,2014-01-22 09:39:00-05:00,KIN,neutral
727133.0,13G Filing from Seth Klarman's Baupost Group Shows 17.93% Stake in Kindred Biosciences,2014-01-09 16:15:00-05:00,KIN,neutral
727134.0,"Director Nodelman Buys 400,000 Shares of Kindred Biosciences -Form 4",2013-12-13 12:15:00-05:00,KIN,positive
